Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-11-17
1978-02-14
Rush, Raymond V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260307B, C07D27106, A01N 936
Patent
active
040738949
ABSTRACT:
This invention discloses new compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from the group consisting of alkyl and ##STR2## WHEREIN A is selected from the group consisting of alkyl, alkoxy, alkylthio, halogen, nitro and cyano; and n is an integer from 0 to 3; X.sup.1, X.sup.2, X.sup.3, Z.sup.1 and Z.sup.2 are independently selected from the group consisting of oxygen and sulfur; m is the integer 0 or 1; and Y is selected from the group consisting of alkyl, alkoxy, alkylthio, amino, alkylamino and dialkylamino. Further disclosed are insecticidal compositions containing as an essential ingredient a compound of the foregoing description.
REFERENCES:
patent: 3534057 (1970-10-01), Krenzer
Stach Leonard J.
Wilke Robert N.
Olesch Dietmar
Rush Raymond V.
Schwarz Robert J.
Velsicol Chemical Corporation
LandOfFree
Oxadiazolidine substituted phosphorus compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazolidine substituted phosphorus compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazolidine substituted phosphorus compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-524657